Daniel E. Greenleaf Appointed as Chief Executive Officer of The Providence Service Corporation and LogistiCare
02 Dicembre 2019 - 2:00PM
The Providence Service Corporation (the “Company” or “Providence”)
(Nasdaq: PRSC) today announced that it has appointed Daniel E.
Greenleaf as Chief Executive Officer of the Company and its
subsidiary, LogistiCare Solutions, LLC (“LogistiCare”), effective
December 11, 2019. Mr. Greenleaf is an innovator across the
healthcare industry who brings over 25 years of experience
successfully transforming healthcare companies through periods of
growth.
“I am thrilled to welcome Dan to the team,” said
Carter Pate, Providence’s interim Chief Executive Officer. “Dan is
a highly respected healthcare leader who has a distinguished track
record of driving operational excellence, enhancing growth and
creating value for shareholders.”
Mr. Greenleaf recently served as President and
CEO of BioScrip, Inc. (“BioScrip”), the largest independent
provider of infusion and home care management solutions, where he
spearheaded the turnaround and successful merger with Option Care
Health (Nasdaq: BIOS). Prior to BioScrip, he was the CEO and
Chairman of Home Solutions Infusion Services where he led the
turnaround and eventual sale to BioScrip. Before Home Solutions
Infusion Services, Mr. Greenleaf was the President and CEO of Coram
Specialty Services, where he was instrumental in growing Coram to
become the top-performing home infusion company in the country
prior to its sale to CVS. Mr. Greenleaf graduated from
Denison University with a Bachelor of Arts in Economics and holds a
Master of Business Administration in Health Administration from the
University of Miami. He is a military veteran, having served as
captain and navigator in the United States Air Force.
“On behalf of the Providence Board, we would
like to thank Carter for the tremendous leadership he brought to
Providence over the past two years,” said Chris Shackelton,
Chairman of the Board of Directors. “His dedication and discipline
drove significant progress through a critical transitional phase,
during which he oversaw an organizational restructuring and
consolidation, as well as asset sales. As a result of his hard
work, the Company has a stronger foundation from which to take
advantage of a terrific set of favorable industry
opportunities.”
“We are pleased to welcome Dan to Providence and
LogistiCare,” Mr. Shackelton continued. “Throughout his career, he
has relentlessly driven high-performing organizations. We are
confident that Dan’s strategic vision, industry knowledge and
proven leadership skills will enable the Company to further
accelerate growth and shareholder value creation. LogistiCare is at
the center of compelling industry trends as a market leader with a
best-in-class organization, terrific technology platform and
unlevered balance sheet. From this position of strength, we believe
the Company will excel with Dan as the CEO.”
“I am incredibly excited to assume this new role
and for the future of the Company,” said Mr. Greenleaf.
“LogistiCare is an industry leader, with an exceptionally talented
management team and a long history of providing high quality
technology-enabled healthcare services to payors and members. I am
committed to driving ongoing transformational change and unlocking
future growth potential for LogistiCare through enhancing
membership experience, strengthening our relationship with payors,
optimizing operational efficiencies, and maximizing value for our
shareholders.”
About Providence and
LogistiCare
The Providence Service Corporation, through its
fully-owned subsidiary LogistiCare Solutions, LLC, is the nation’s
largest manager of non-emergency medical transportation programs
for state governments and managed care organizations. Its
range of services includes call center management, network
credentialing, vendor payment management and non-emergency medical
transport management. The Company also holds a minority
interest in Matrix Medical Network which provides a broad array of
assessment and care management services to individuals that improve
health outcomes and health plan financial performance. For
more information, please visit prscholdings.com.
Forward Looking Statements
Certain statements contained in this press
release constitute “forward-looking statements” within the meaning
of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements are based on our current expectations,
assumptions, estimates and projections about our business and our
industry, and are not guarantees of our future performance.
These statements are subject to a number of known and unknown
risks, uncertainties and other factors which may cause actual
events to be materially different from those expressed or implied
by such forward-looking statements herein. These risks,
uncertainties and other factors include, but are not limited to,
the risks disclosed in our Annual Report on Form 10-K and
subsequent filings with the Securities and Exchange
Commission. You are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date
the statement was made. We undertake no obligation to update
or revise any forward-looking statements contained in this release,
whether as a result of new information, future events or otherwise,
except as required by applicable law.
Investor Relations ContactBryan
Wong – Investor Relations(404) 888-5902
Grafico Azioni BioPlus Acquisition (NASDAQ:BIOS)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni BioPlus Acquisition (NASDAQ:BIOS)
Storico
Da Gen 2024 a Gen 2025